Impact of kinesin Eg5 inhibition by 3,4-dihydropyrimidin-2(1H)-one derivatives on various breast cancer cell features.
about
The kinesin Eg5 inhibitor K858 induces apoptosis but also survivin-related chemoresistance in breast cancer cells.Identification of novel scaffolds to inhibit human mitotic kinesin Eg5 targeting the second allosteric binding site using in silico methods.Kinesin superfamily: roles in breast cancer, patient prognosis and therapeutics.
P2860
Impact of kinesin Eg5 inhibition by 3,4-dihydropyrimidin-2(1H)-one derivatives on various breast cancer cell features.
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Impact of kinesin Eg5 inhibiti ...... s breast cancer cell features.
@ast
Impact of kinesin Eg5 inhibiti ...... s breast cancer cell features.
@en
type
label
Impact of kinesin Eg5 inhibiti ...... s breast cancer cell features.
@ast
Impact of kinesin Eg5 inhibiti ...... s breast cancer cell features.
@en
prefLabel
Impact of kinesin Eg5 inhibiti ...... s breast cancer cell features.
@ast
Impact of kinesin Eg5 inhibiti ...... s breast cancer cell features.
@en
P2093
P2860
P50
P1433
P1476
Impact of kinesin Eg5 inhibiti ...... us breast cancer cell features
@en
P2093
Brenno A D Neto
Bruna C Guido
Bárbara Y G Andrade
Catharine C Nobrega
P2860
P2888
P356
10.1186/S12885-015-1274-1
P407
P577
2015-04-14T00:00:00Z
P5875
P6179
1026257785